MetLife, Inc.

Fundamentals6.0
Price Action6.0
News Sentiment7.0
AI Rating
6.0

Key Drivers

  • Cash Strength
  • Balance-Sheet Risk
  • Dividend Pressure

AI
AI Summary

6.0

MET now looks more like a cash-generating capital-return story than a slow insurer, with the Q2 beat and $3B buyback supporting per-share upside, but the stock is unlikely to rerate decisively until GAAP earnings and revenue consistently narrow the gap to adjusted results amid heavy leverage and rate/spread sensitivity.

CapitalReturn
Leverage
Rerating‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • Cash Strength
  • Balance-Sheet Risk
  • Dividend Pressure

MetLife appears fundamentally solid with steady earnings, strong cash flow, and fair valuation, but its extremely high leverage and weak latest-quarter dividend coverage make balance-sheet risk the key watchpoint.

CashFlow
Leverage

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Uptrend intact
  • $100 ceiling
  • $96 support

MET has stayed in a constructive uptrend over the last month, but it must clear the $100 resistance area and hold support near $96.0-$96.7 to confirm the rally.

Uptrend
Resistance
Support Level: $96.0-$96.7
Resistance Level: $100 area

The stock recovered from a $91.97 dip, then stalled after reaching $99.95

Sentiment & News

7.0

Key News Insights:

  • Earnings Beat
  • Capital Return
  • Global Growth

MetLife delivered a strong Q2 beat with 15% EPS growth, a 17% adjusted ROE, and a new $3B buyback, underscoring solid capital generation and shareholder returns.

Earnings
Buyback

The results are a positive read-through for MetLife, supporting confidence in earnings momentum, underwriting strength, and ongoing capital deployment